Home
/ TYME
/ Competitors

TYME Competitors and Similar CompaniesClear all

TYME's competitors and similar companies include Memgen, Kite Pharma, Oscotec and Karo Healthcare.

	TYME TYME Technologies is a biotechnology company that develops cancer therapeutics.	Memgen Memgen is a clinical-stage biotechnology company.	Kite Pharma Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.	Oscotec Oscotec is a clinical stage drug discovery and development company.	Karo Healthcare Karo Healthcare is a healthcare company, which develops and markets products for pharmacies and the health care sectors.
Founding Date	Founding Date 2011	Founding Date 2004	Founding Date 2009	Founding Date 1998	Founding Date 1987
Type	Type Public	Type Private	Type Subsidiary	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy
Locations	Locations New York, US HQ Bedminster, US	Locations Houston, US HQ	Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more	Locations Seongnam-si, KR HQ	Locations Stockholm, SE HQ Stockholm, SE
Employees	Employees 15	Employees 7	Employees 3,9671% decrease	Employees 50	Employees 225
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₩99.8b (FY, 2025)	Revenue (est.) kr3b (FY, 2021)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ₩438.8m (FY, 2025)	Cost of goods kr1.3b (FY, 2021)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ₩100b (FY, 2025)	Gross profit kr1.7b (FY, 2021)
Net income	Net income ($23.6m) (FY, 2022)	Net income N/A	Net income N/A	Net income ₩54.4b (FY, 2025)	Net income (kr17m) (FY, 2021)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 8.5m	Total funding raised $ 85.3m	Total funding raised N/A	Total funding raised N/A